MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
62.00
-1.57 (-2.47%)
Jul 24, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $2.95 billion as of July 24, 2026. Its market cap has increased by 545.40% in one year.
Market Cap
2.95B
Enterprise Value
2.51B
1-Year Change
545.40%
Ranking
Category
Stock Price
$62.00
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $2.95B, an increase of 479.02%. That is a compound annual growth rate of 157.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 2.95B | 108.38% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 3.42B |
| IDEAYA Biosciences | 3.37B |
| Disc Medicine | 2.83B |
| Celldex Therapeutics | 2.77B |
| uniQure | 2.68B |
| AtaiBeckley | 2.66B |
| Ultragenyx Pharmaceutical | 2.64B |
| Kodiak Sciences | 2.59B |